References
- BaumgartDCThe diagnosis and treatment of Crohn’s disease and ulcerative colitisDtsch Arztebl Int200910612313319568370
- CohenRDThe quality of life in patients with Crohn’s diseaseAliment Pharmacol Ther2002161603160912197839
- JankeKHKlumpBGregorMMeisnerCHaeuserWDeterminants of life satisfaction in inflammatory bowel diseaseInflamm Bowel Dis20051127228615735434
- DignassAVanAGLindsayJOThe second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current managementJ Crohns Colitis20104286221122489
- AllenPBLindsayHThamTCHow do patients with inflammatory bowel disease want their biological therapy administered?BMC Gastroenterol201010120064220
- ShikiarRRentzAMSatisfaction with medication: an overview of conceptual, methodologic, and regulatory issuesValue Health2004720421515164810
- OliverRLSatisfaction: A Behavioral Perspective on the ConsumerNew YorkMcGraw-Hill1997
- Dias BarbosaCBalpMMKulichKGermainNRofailDA literature review to explore the link between treatment satisfaction and adherence, compliance, and persistencePatient Prefer Adherence20126394822272068
- AtkinsonMJSinhaAHassSLValidation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic diseaseHealth Qual Life Outcomes200421214987333
- RuizMAPardoARejasJSotoJVillasanteFArangurenJLDevelopment and validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED-Q)Value Health20081191392618494753
- CoyneKJoshua-GotlibSKimelMThompsonCLewisADanilewitzMValidation of the Treatment Satisfaction Questionnaire for Crohn’s Disease (TSQ-C)Dig Dis Sci20055025225815745081
- ClarkMColombelJFFeaganBCAmerican gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21–23, 2006Gastroenterology200713331233917631151
- MarantCArnouldBMarrelAAssessing patients’ satisfaction with anti-TNFalpha treatment in Crohn’s disease: qualitative steps of the development of a new questionnaireClin Exp Gastroenterol2011417318021904463
- US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological HealthGuidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdfAccessed October 3, 2014
- Mapi Research TrustSatisfaction of PAtients with Crohn’s diseasE (SPACE) [webpage on the internet] Available from: http://www.proqolid.org/instruments/satisfaction_of_patients_with_crohn_s_disease_spaceAccessed October 3, 2014
- CampbellDTFiskeDWConvergent and discriminant validation by the multitrait-multimethod matrixPsychol Bull1959568110513634291
- ChassanyOSagnierPMarquisPFullertonSAaronsonNPatient-reported outcomes: the example of health-related quality of life: a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory processDrug Inf J200236209238
- HarveyRFBradshawJMA simple index of Crohn’s disease activityLancet198015146102236
- NunnallyJCBernsteinIHPsychometric Theory3rd edNew YorkMcGraw-Hill Inc1994
- StreinerDLBeing inconsistent about consistency: when coefficient alpha does and doesn’t matterJ Pers Assess20038021722212763696
- GuyattGHDeyoRACharlsonMLevineMNMitchellAResponsiveness and validity in health status measurements: a clarificationJ Clin Epidemiol1989424034082659745
- CohenJStatistical Power Analysis for the Behavioral SciencesNew YorkAcademic Press1977
- VavrickaSRSchoepferAMBanskyGEfficacy and safety of certolizumab pegol in an unselected Crohn’s disease population: 26-week data of the FACTS II surveyInflamm Bowel Dis2011171530153921674709
- SchreiberSCertolizumab pegol for the treatment of Crohn’s diseaseTherap Adv Gastroenterol20114375389
- CassinottiAArdizzoneSPorroGBAdalimumab for the treatment of Crohn’s diseaseBiologics2008276377719707457
- CavigliaRBoskoskiICicalaMMaintenance treatment with infliximab for the management of Crohn’s disease in adultsBiologics20093394919707394